Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.


From bench to bedside...and back again

Our translational and clinical researchers collaborate to convert conceptual breakthroughs into novel therapies that will benefit our patients. They work in multidisciplinary teams that focus on translational research targeting individual cancers, as well as those focused on basic research that crosses multiple diseases across the cancer continuum.


Meyer Cancer Center Cancer Biology ProgramCancer Biology Meyer Cancer Center Cancer Genetics and EpigeneticsCancer Genetics and Epigenetics

Meyer Cancer Center Experimental TherapeuticsExperimental Therapeutics Cancer Prevention & ControlCancer Prevention & Control


Study of breast cancer metastasis upends conventional wisdom

Breast cancer cells do not undergo a commonly accepted transformation in order to spread to distant organs. The discovery, made in the labs of Ding Cheng Gao, Ph.D., and Vivek Mittal, Ph.D. may settle a longstanding debate about how cancers spread and profoundly change the way many forms of the disease are treated.


Collaborative Research Initiative announces inaugural award winners : 

Dr.Yariv Houvras, right, with Dr. Ritu Kumar, an assistant professor of cell and developmental biology in surgery.Dr.Yariv Houvras, right, with Dr. Ritu Kumar, an assistant professor of cell and developmental biology in surgery. Four interdisciplinary teams of physicians and scientists from Weill Cornell Medicine have been announced as recipients of the Sandra and Edward Meyer Cancer Center's inaugural Collaborative Research Initiative pilot project grants.

  • Nutrition-Based Immune Reprogramming to Enhance Cancer Immunotherapy
  • Overcoming Gastric Cancer Treatment Resistance by Targeting CLIP-170S: a Molecular, Computational, and Translational Program
  • Mechanisms of Telomere Maintenance in Acute Myeloid Leukemia and Therapeutic Potential
  • Functional Characterization of DNA Regulatory Regions Recurrently Deleted in Human Cancer